DECN.US Decision Diagnostics

Healthcare Health Care Technology USA Stocks
0.0001 USD
Close of Oct 6, 2026
0.0001 0.0001
Market cap
USD 35.8K
P/E
-
P/B
2.72x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2021.

Is DECN.US undervalued?

Graham number

The Graham number of Decision Diagnostics cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Decision Diagnostics fundamental analysis

No fundamental analysis for Decision Diagnostics yet.

Decision Diagnostics stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Decision Diagnostics

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the chronically ill; fulfillment services to direct to patient diabetes programs; and cell phone centric e-health products and technologies development services. It manufactures and distributes GenUltimate! glucose test strips, a Class II medical device for at-home use for the measureme…

Full company profile